(4-((2-Methoxy-2-oxoethyl)carbamoyl)phenyl)boronic acid, 98%, 250mg

2-Bromo-6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazole, 97%, 1g

2-Bromo-5-methoxyphenol, 95.0%, 500g

(R)-6,7-Dihydro-5H-pyrrolo[1,2-a]imidazol-6-ol, 95+%, 50mg

(5S)-5-(2-hydroxyethyl)-2-pyrrolidinone, 95.0%, 1g

2,5-Bis(pyrid-4-yl)pyridine, 98%, 1g

3-[4'-(Dimethylamino)[1,1'-biphenyl]-3-yl]-1,1-dimethylurea, >98.0%(HPLC)(T), 5mg

Columna capilar GC ROTI®Cap-1, 30 m, 0,53 mm, 0,50 µm, 1 Pieza(s)

(S)-4-(6-(3,5-Dimethylisoxazol-4-yl)-1-(1-(pyridin-2-yl)ethyl)-1H-pyrrolo[3,2-b]pyridin-3-yl)benzoic acid, 98.00%, 50mg

3-(Hexadecyloxy)propan-1-ol, 95.0%, 100mg

2-[4-(2-Benzimidazolyl)phenyl)]-5-methyl-4-phenylthiazole, 1g

[5-(4-Trifluoromethyl-phenyl)-[1,2,4]oxadiazol-3-yl]-acetic acid ethyl ester, 95.0%, 500mg

1-(2,4-Dichloro-benzenesulfonyl)-2-methyl-piperazine hydrochloride, 95.0%, 250mg